ライフサイエンスコーパス: immunogenetic

1 the potential to revolutionize the field of immunogenetics.

2 l selection approaches toward resolving H Ag immunogenetics.

3 autoimmune basis that is influenced by host immunogenetics.

4 odel for infectious diseases and comparative immunogenetics.

5 n scan may provide further insights into IIM immunogenetics.

6 To update the reader on immunogenetic advances in idiopathic inflammatory myopat

7 Published ethnogeographic immunogenetic allele frequencies imply that the striking

8 In our immunogenetic analyses of 429 HIV-1 discordant Zambian c

9 usion, Easy-HLA tools facilitate large-scale immunogenetic analysis and promotes the multi-faceted HL

10 Interestingly, immunogenetic analysis indicates that m826 is a germline

11 Over the last decade, immunogenetic analysis of B-cell receptor immunoglobulin

12 Immunogenetic analysis of disease susceptibility has bee

13 Immunogenetic analysis of experimental colitis may contr

14 Immunogenetic analysis revealed a significant increase i

15 Immunogenetic analysis showed that TLR1, TLR6, and TLR10

16 ch impacts on all main applications of IG/TR immunogenetic analysis.

17 This specificity may identify a further immunogenetic and clinical phenotype within the juvenile

18 Further evidence supports the interaction of immunogenetic and environmental factors in the etiology

19 nd Risk Stratification and Identification of Immunogenetic and Microbial Markers of Rapid Disease Pro

20 followed up over a period of 3-29 years with immunogenetic and systematic clinical and serologic anal

21 uncovered minute subclones carrying genomic, immunogenetic and transcriptomic features of RT cells al

22 Here, we perform a comprehensive immunogenetic and virologic analysis of nasopharyngeal a

23 is to summarize new findings in the field of immunogenetics and HCT from unrelated donors using myelo

24 Improving the understanding of the immunogenetics and immunopathogenesis of the IIMs may in

25 imal models have been limited by the complex immunogenetics and lack of defined ligands for KIRs in n

26 Here, we highlight recent advancements in immunogenetics and provide a forward-looking view of the

27 information about rubella-containing vaccine immunogenetics and review the emerging evidence of inter

28 American Society for Histocompatibility and Immunogenetics and the United Network for Organ Sharing

29 ed insights into host-pathogen interactions, immunogenetics, and viral evolution in both humans and m

30 phocytosis syndrome, a disease in which host immunogenetics appear to be the determining factor, and

31 The aim of this study is to develop an immunogenetic approach for identifying and quantifying t

32 In this report we use a reverse immunogenetic approach to predict possible HLA class II-

33 An immunogenetic approach was then used to further study th

34 edicine could thus be mitigated, in part, by immunogenetic approaches.

35 e of various autoantibodies; and 4) a strong immunogenetic association.

36 Immunogenetic associations have previously been describe

37 Complex immunogenetic associations of disease involving a large

38 nt linear statistical methods for evaluating immunogenetic associations of disease.

39 systematic studies on the natural history or immunogenetic associations of erythema nodosum (EN) or o

40 Immunogenetic associations with cytokine polymorphisms a

41 ermine their frequencies and any clinical or immunogenetic associations.

42 trate the importance of considering the host immunogenetic background in the analysis of immune respo

43 investigated breadth of the T-cell response, immunogenetic background, and viral escape from CD8+ lym

44 ical properties of tau variants on a uniform immunogenetic background, we created somatic transgenesi

45 n autoimmune liver disease based on a strong immunogenetic background.

46 environmental agents, acting upon different immunogenetic backgrounds, result in distinct immune res

47 suggests that both disorders have a similar immunogenetic basis and are parts of a single disease pr

48 We conclude that the immunogenetic basis for HCV clearance differs between et

49 The immunogenetic basis of GVHD has been the subject of inte

50 Better understanding of the immunogenetic basis of susceptibility to HPV-associated

51 the sociodemographic, clinical, immunologic, immunogenetic, behavioral, and psychological domains wer

52 Socioeconomic, immunologic, immunogenetic, behavioral, and psychological variables w

53 economic/demographic, clinical, immunologic, immunogenetic, behavioral, and psychological) were measu

54 conomic, demographic, clinical, immunologic, immunogenetic, behavioral, and psychological) were measu

55 es in children with Down's syndrome, but the immunogenetic characteristics of diabetes in Down's synd

56 To determine the immunogenetic characteristics of patients with immune-me

57 therefore be highly desirable and enable the immunogenetic characterization of samples in currently o

58 However, important immunogenetic, clinical, and psychosocial differences be

59 These patients demonstrated the typical immunogenetic, clinical, and serologic findings of MCTD,

60 similar treatments show value in a stronger immunogenetic combination, i.e., BALB/c to C57BL/6, and

61 confirmatory sequences are dispersed to the immunogenetics community, and the wider research and cli

62 architecture for schizophrenia with a modest immunogenetic component.

63 immunoregulation and to address the role of immunogenetic components in the production of pathogenic

64 h a solid basis for unbiased benchmarking of immunogenetics computational tools.

65 This review focuses on current immunogenetic concepts, key cellular players, and axes o

66 Immunogenetic correlates of resistance to HIV-1 in HIV-1

67 e field, which have finally enabled detailed immunogenetic data to be incorporated into NHP transplan

68 underscores the need for population-specific immunogenetic data to guide T-cell vaccine development.

69 present MiDAS, a comprehensive R package for immunogenetic data transformation and statistical analys

70 we analysed 8593 patients with CLL for whom immunogenetic data were available.

71 ely half were not found in the International Immunogenetics Database (IMGT).

72 rmined by using sequence comparison with the ImMunoGeneTics database, and their chromosomal locations

73 r immune dysfunction in NDDs, including rare immunogenetic disorders with neurodevelopmental impacts,

74 Grafts with different immunogenetic disparities were chosen to test expression

75 ced graft-versus-host disease (GVHD) in both immunogenetic disparities, leading to substantially atte

76 Because the donor and recipient have greater immunogenetic disparity than related donor transplants,

77 tions from infectious diseases by preserving immunogenetic diversity and disease resistance.

78 icate that population connectivity maintains immunogenetic diversity in bighorn sheep populations in

79 ues that confront the virus when adapting to immunogenetic diversity in the host.

80 R did not, highlighting a loss of functional immunogenetic diversity that may be associated with Bd s

81 sheep populations was correlated with higher immunogenetic diversity, a protective immune response an

82 d structural plasticity of a highly selected immunogenetic element.

83 rity of biobanks are reshaping the future of immunogenetics, enabling breakthroughs at a pace never b

84 ve given us clues in elucidating the role of immunogenetic, environmental influences on the etiopatho

85 In this immunogenetic epidemiological study we first computed a

86 These findings provide immunogenetic evidence for differentiating the two disea

87 These results are convergent with immunogenetic evidence implicating lymphoid cell dysregu

88 findings identify the MHC-related MICA as an immunogenetic factor that may functionally influence ant

89 ular mucosal disease may point to a distinct immunogenetic factor that predisposes patients to develo

90 phenotype is associated with beneficial host immunogenetic factors (such as HLA-B*57) as well as with

91 techniques to evaluate associations between immunogenetic factors and post-traumatic sepsis and sept

92 Immunogenetic factors are considered important in its pa

93 The immunogenetic factors that influence susceptibility to p

94 However, the immunogenetic factors that influence these outcomes are

95 Other immunogenetic factors that regulate superantigen respons

96 l and peripheral inflammatory mechanisms and immunogenetic factors.

97 s, and medication usage and autoantibodies), immunogenetic features (HLA class II genotypes), and beh

98 in multiple genes as well as cytogenetic and immunogenetic features distinguished NNK- from DMT-SMZLs

99 inical, histological, immunopathological and immunogenetic features indicate that these patients have

100 We report the clinical, histopathologic, and immunogenetic features of a new case of L-tryptophan-ass

101 s, we evaluated the clinical, serologic, and immunogenetic features of Mestizo (Mexican and Guatemala

102 To determine the clinical and immunogenetic features of systemic sclerosis (SSc) patie

103 analysis of 177 MCL to determine whether the immunogenetic features of the clonotypic B-cell receptor

104 ent a characteristic pattern of clinical and immunogenetic features that may have implications regard

105 hnologies uncovered genetic, epigenetic, and immunogenetic features underpinning FL, offering insight

106 hed between epitypes, we found highly biased immunogenetic features, including IGLV3-21 usage in the

107 of marrow infiltration, immunophenotypic, or immunogenetic findings at diagnosis did not distinguish

108 e British Society for Histocompatibility and Immunogenetics Flow Cytometry Group, a series of crossma

109 This atlas deepens our understanding of the immunogenetic functions of disease-associated variants u

110 This immunogenetics-guided discovery of the limited binding s

111 diated immune response leading to rejection (immunogenetics) has enhanced understanding of antibody-m

112 both organs are transplanted simultaneously (immunogenetic identity), but not for kidneys transplante

113 Studying the interaction among immunogenetics, immune responses, and viral sequences fr

114 receptor (BCR/TCR) architecture to identify immunogenetic imprints of autoimmunity.

115 To dissect the role of immunogenetics in allergy and asthma, we performed a phe

116 tant studies have outlined the importance of immunogenetics in conferring risks for invasive fungal i

117 American Society for Histocompatibility and Immunogenetics in Pittsburgh, PA (USA) and focused on re

118 To further define immunogenetics in the pathogenesis of idiopathic achalas

119 results suggest a possible role for cytokine immunogenetics in the stability of peripheral tolerance.

120 rts: the demultiplex tool, the international ImMunoGeneTics information system (IMGT) concatenate too

121 4-Cys86, and Cys45-Cys100; the international ImMunoGeneTics information system numbering), whose pres

122 This study offers immunogenetic insight into the basis of COVID-19 disease

123 lecting broader trends in bioinformatics and immunogenetics, IPD-MHC now includes the predicted terti

124 ransplant centers, 19 histocompatibility and immunogenetics laboratories, transport providers, and Na

125 mechanisms at both the germline and somatic immunogenetic levels results in diversity in knob region

126 Human leukocyte antigen immunogenetics likely play a substantial role.

127 However, association studies involving immunogenetic loci most commonly involve simple analyses

128 her H-2d or the BALB background contains the immunogenetic makeup necessary for the production of pat

129 The immunogenetic makeup of the host was important for this

130 ing to ME/CFS is modulated by the host's HLA immunogenetic makeup.

131 ebrafish lines are an indispensable tool for immunogenetics, mapping of quantitative trait loci and o

132 vealed a significant age-related decrease in immunogenetic maturation, where IG kappa rearrangements

133 It highlights the higher immunogenetic maturity in children, which may be explain

134 These results support an immunogenetic mechanism in the pathogenesis of idiopathi

135 alasia has been found, suggesting a possible immunogenetic mechanism.

136 Immunogenetic mechanisms operating within the immune sys

137 inically, their pathogenesis involves shared immunogenetic mechanisms.

138 d American Society of Histocompatibility and Immunogenetics membership.

139 The immunogenetics of BMC rejection are largely controlled b

140 environment in which to evaluate the role of immunogenetics of both the donor and the recipient to su

141 ronic rejection may provide insight into the immunogenetics of chronic rejection and help prevent fur

142 most relevant aspects in the context of the immunogenetics of CLL, while at the same time provoking

143 Further research is warranted concerning the immunogenetics of GCA.

144 The pathogenesis of liver injury, the immunogenetics of HCV infection, and the effect of HCV i

145 nce in understanding of natural recovery and immunogenetics of HCV might set the stage for much neede

146 mmune complex, but little is known about the immunogenetics of pathogenic response.

147 The simple immunogenetics of the CD1 system and new investigative t

148 l reaction and provide new insights into the immunogenetics of the disease.

149 We report here that the immunogenetics of the host influence the outcome of inva

150 d the controversies in antiviral therapy and immunogenetics of this cancer and may provide a basis fo

151 nd are consistent with a common ontogeny and immunogenetic origin for these 2 epidemiologically disti

152 DA2 from healthy individuals on the basis of immunogenetic parameters regarding B-cell clone fraction

153 (along gradients) and describe how variable immunogenetic pathways aggregate (into networks) to affe

154 Here, we present novel immunogenetic pathways and discuss their impact on tradi

155 om a morphological, immunohistochemical, and immunogenetic perspective.

156 ientific areas including histocompatibility, immunogenetics, pharmacogenetics and anthropology studie

157 ns dovetail with the roles of these genes in immunogenetic phenotypes and adverse drug responses for

158 CCR2-V64I, an immunogenetic polymorphism linked to LTSs, was detected

159 ts extend our knowledge on the importance of immunogenetic polymorphisms and NK cell-Ab interplay in

160 ndidate gene studies have implicated several immunogenetic polymorphisms in human infectious diseases

161 lor treatment to the clinicopathological and immunogenetic profile of the individual patient.

162 affinities to the breast cancer-HLA (BC-HLA) immunogenetic profile of the same alleles.

163 estingly, a distinctive immunophenotypic and immunogenetic profile was identified for primary splenic

164 obtained full-length HIV-1 RNA sequences and immunogenetic profiles from 6 untreated women enrolled i

165 with PPH and HIV infection have distinctive immunogenetic profiles.

166 Immunogenetic profiling in patients at clinical high ris

167 We performed an immunogenetic profiling of 333 cases with CLL-like MBL s

168 e plasmablasts and memory B cells, and their immunogenetic properties were characterized.

169 e database of known human defense genes: the Immunogenetic Related Information Source (IRIS).

170 r inflammation and EN and their clinical and immunogenetic relationship to arthritis in IBD.

171 studies, yet their B cell immunobiology and immunogenetics remain ill-characterized.

172 r data show that KIR-human leukocyte antigen immunogenetics represent a novel prognostic tool for pat

173 LA interactions, with broad applicability to immunogenetic research and clinical decision-making.

174 identifying some of the limitations of prior immunogenetic research in ASD.

175 nes, leading to inaccuracies that can impede immunogenetic research.

176 nAIR represents a significant advancement in immunogenetics research and antibody engineering, provid

177 d should be of value to ongoing genomics and immunogenetic resistance studies in this shrimp of param

178 Immunogenetics revealed overusage of the IGHV4-34 gene a

179 Our data shed light on the immunogenetic risk associated with IAA etiology and clon

180 onal relationships between the soil trigger, immunogenetic risk factors and the immunological basis o

181 ologic findings, associated autoantibody and immunogenetic risk factors are discussed.

182 o remain disease free with the same level of immunogenetic risk; and 3) efforts to identify where the

183 miologic data, providing an understanding of immunogenetic risks for infection, and optimizing preven

184 e system, which results in a highly specific immunogenetic signature in patients with DADA2.

185 In contrast, HC-MBL exhibited clear immunogenetic similarities to CLL-0.

186 Despite clinical and immunogenetic similarities with both the ACA- and anti-t

187 ilar to those in humans, including conserved immunogenetic, structural, and chemical solutions to epi

188 fectiveness of the available treatments, and immunogenetic studies are ongoing to further elucidate I

189 Immunogenetic studies have demonstrated a strong associa

190 Immunogenetic studies have identified that various activ

191 od mononuclear cells, with ramifications for immunogenetic studies of psoriasis and other autoimmune

192 Immunogenetic studies of the clonotypic BCR Ig of CLL su

193 Immunogenetic studies showed the presence of the DR3 all

194 these variant phenotypes would be useful for immunogenetic studies.

195 ands and will inform genetic association and immunogenetics studies examining the role of KIR3DL1 in

196 nological advances that are facilitating the immunogenetic study of IEIs, progress in understanding d

197 Here, through a broad immunogenetic study, we demonstrate that germline and so

198 ct mechanisms of aggressiveness in different immunogenetic subsets of CLL.

199 ethnic groups have both shared and distinct immunogenetic susceptibility factors, depending on the c

200 This suggests an interplay between immunogenetic susceptibility, immune dysregulation, bact

201 cluding environmental triggers; familial and immunogenetic susceptibility; and potential T cell cytot

202 in-like receptor (KIR) genes form a diverse, immunogenetic system.

203 e American Society of Histocompatibility and Immunogenetics that aims at providing recommendations fo

204 Here, we present the PING (Pushing Immunogenetics to the Next Generation) pipeline, which i

205 ng a combination of cellular, molecular, and immunogenetics tools, we collected cerebrospinal fluid f

206 rent immunological status, rather than fixed immunogenetic traits.

207 Hence, to gain insights on the immunogenetic underpinnings of ASD, we conducted a syste

208 These findings further expand our immunogenetic understanding of mechanisms of rubella vac

209 Our review confirms the presence of immunogenetic variability in ASD, accounted by inherited

210 ables associated with cancer instability and immunogenetic variability in humans.

211 Extensive analyses of non-HLA immunogenetic variants have also been undertaken and ass

212 We further show that these MS-associated immunogenetic variants underwent positive selection both

213 Our findings demonstrate that immunogenetic variation affects chytridiomycosis surviva

214 thus closes the gap between the inference of immunogenetic variation and its efficient utilization to

215 Accordingly, assessing immunogenetic variation and the functional implications

216 Understanding the role of immunogenetic variation in risk for CMV infection can pr

217 Human immunogenetic variation in the form of HLA and KIR types

218 Host immunogenetic variations strongly influence the severity

219 This is the first study to investigate immunogenetic variations that might account for HPV susc